| 新冠疫苗核心免疫原的专利分析 |
| |
| 引用本文： | 魏应亮,艾超仁,赵永江.新冠疫苗核心免疫原的专利分析[J].中国发明与专利,2021(3). |
| |
| 作者姓名： | 魏应亮 艾超仁 赵永江 |
| |
| 作者单位： | 国家知识产权局专利局专利审查协作湖北中心 |
| |
| 摘 要： | 本文基于已公布的新冠病毒(COVID-19)疫苗专利或文献,分析了我国目前研发的新型冠状病毒疫苗核心免疫原,着重关注其中可能涉及的S-2P知识产权风险,并对我国利用该技术发展相关疫苗提出了建议。
|
| 关 键 词： | 新型冠状病毒 疫苗 S-2P 专利 风险 |
Patent Analysis of Viral Targets for Vaccines Against COVID-19 |
| |
| WEI Yingliang,AI Chaoren,ZHAO Yongjiang.Patent Analysis of Viral Targets for Vaccines Against COVID-19[J].China Invention & Patent,2021(3). |
| |
| Authors: | WEI Yingliang AI Chaoren ZHAO Yongjiang |
| |
| Institution: | (Patent Examination Cooperation Hubei Center of the Patent Office,CNIPA,Wuhan 430075) |
| |
| Abstract: | Based on the published patents or journal of the new coronavirus(COVID-19)vaccine,we discuss which viral elements are used in COVID-19 vaccine candidates in our country,focusing on the possible S-2P intellectual property risks involved,and provide appropriate suggestions for development of S-2P technology in vaccine. |
| |
| Keywords: | COVID-19 vaccine S-2P patent risk |
| 本文献已被 CNKI 维普 等数据库收录！ |
